Psoriasis meeting highlights - Toronto Dermatology Centre
Call Us Today: 416.633.0001
Call Us Today:416.633.0001

Psoriasis meeting highlights

Dr. Barankin and Dr. Freiman just attended a 2-day psoriasis meeting where they learned about psoriasis diagnosis and treatment, as well as the related health problems (“comorbidities”) that many psoriasis patients face; here are some of the highlights:

  • Patients with severe psoriasis live on average 3-4 years less.
  • Depression, anxiety and suicide are all increased in psoriasis patients ; it turns out that psoriasis and depression may have common underlying pathways (e.g. inflammation). Interestingly, depression and anxiety have been shown to improve with the biologic drugs (e.g. adalimumab, etanercept, ustekinumab).
  • Obesity is a risk factor for developing psoriasis.
  • Patients with psoriasis are at higher risk of increased triglycerides and cholesterol.
  • Psoriasis has been associated with increased alcohol use
  • Biologic drugs such as etanercept and adalimumab significantly reduce heart attacks as compared to methotrexate or phototherapy, and they prevent the progression of psoriatic arthritis.
  • Inflammatory bowel disease is 10 times more common in patients with psoriasis.
  • Celiac disease is also more common in psoriasis patients.

Leave a reply

Subscribe to Our Newsletter

Make an Inquiry